990 related articles for article (PubMed ID: 19371615)
1. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
2. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T
Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864
[TBL] [Abstract][Full Text] [Related]
3. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
5. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
6. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
7. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
8. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes.
Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T
Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130
[TBL] [Abstract][Full Text] [Related]
9. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
10. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis.
Jiang G; Park K; Kim J; Kim KS; Hahn SK
Mol Pharm; 2009; 6(3):727-37. PubMed ID: 19178144
[TBL] [Abstract][Full Text] [Related]
11. Effect of poly(ethylene imine) molecular weight and pegylation on organ distribution and pharmacokinetics of polyplexes with oligodeoxynucleotides in mice.
Fischer D; Osburg B; Petersen H; Kissel T; Bickel U
Drug Metab Dispos; 2004 Sep; 32(9):983-92. PubMed ID: 15319340
[TBL] [Abstract][Full Text] [Related]
12. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration.
de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G
Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859
[TBL] [Abstract][Full Text] [Related]
13. PEGylated polyethylenimine for in vivo local gene delivery based on lipiodolized emulsion system.
Hong JW; Park JH; Huh KM; Chung H; Kwon IC; Jeong SY
J Control Release; 2004 Sep; 99(1):167-76. PubMed ID: 15342189
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution and tissue expression kinetics of plasmid DNA complexed with polyethylenimines of different molecular weight and structure.
Jeong GJ; Byun HM; Kim JM; Yoon H; Choi HG; Kim WK; Kim SJ; Oh YK
J Control Release; 2007 Mar; 118(1):118-25. PubMed ID: 17250923
[TBL] [Abstract][Full Text] [Related]
15. A single-monomer derived linear-like PEI-co-PEG for siRNA delivery and silencing.
Tsai LR; Chen MH; Chien CT; Chen MK; Lin FS; Lin KM; Hwu YK; Yang CS; Lin SY
Biomaterials; 2011 May; 32(14):3647-53. PubMed ID: 21324524
[TBL] [Abstract][Full Text] [Related]
16. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
18. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the effect of PEGylation on polyethylenimine in vivo using nuclear imaging technique.
Kim EM; Jeong HJ; Park IK; Cho CS; Bom HS; Kim CG
Nucl Med Biol; 2004 Aug; 31(6):781-4. PubMed ID: 15246369
[TBL] [Abstract][Full Text] [Related]
20. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]